Clinical Trial Update: Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II results are reported for a regimen of Velcade (bortezomib) with Decadron (dexamethasone) and Doxil (liposomal doxorubicin), followed by cyclophosphamid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Decadron (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Velcade (bortezomib)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-07-18